Table 2.
Common symptoms | Laboratory findings | ||
Fever | 77.4–98.6% | Lymphopenia | 35.3–82.1% |
Cough | 59.4–81.8% | Thrombocytopenia | 5.0–36.2% |
Fatigue | 38.1–69.6% | Leukopenia | 9.1–33.7% |
Dyspnea | 3.2–55.0% | Increased CRP | 60.7–86.3% |
Myalgia | 11.1–34.8% | Increased d-dimer | 36.4–46.4% |
Sputum production | 28.2–56.5% | Increased LDH | 27.4–75.8% |
Headache | 6.5–33.9% | Increased CK | 8.0–32.5% |
Underlying diseases | 25.2–50.5% | Prolonged prothrombin time | 58.0% |
Complication | Increased ALT | 16.1–28.3% | |
ARDS | 3.4–29.3% | Increased AST | 22.2–36.7% |
Shock | 1.0–8.7% | Increased interleulin-6 | 51.5% |
Acute renal injury | 0.5–7.3% | Increased serum fenitin | 62.6% |
Acute cardiac injury | 7.2–12.2% | Increased ESR | 84.8% |
Secondary infections | 9.8% | Increased procalcitonin | 5.5–11.3% |
Increased troponin I | 12.2% | ||
Increased creatinine | 1.9–9.8% |
ARDS, acute respiratory distress syndrome; CRP, C-reactive protein; LDH, lactose dehydrogenase; CK, creatinine kinase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ESR, erythrocyte sedimentation rate